Literature DB >> 22431542

Monoallelic and biallelic deletions of 13q14.3 in chronic lymphocytic leukemia: FISH vs miRNA RT-qPCR detection.

Matthew T Smonskey1, AnneMarie W Block, George Deeb, Asher A Chanan-Khan, Zale P Bernstein, Kena C Miller, Paul K Wallace, Petr Starostik.   

Abstract

Deletion of 13q14.3 (del(13q)) is the most common cytogenetic abnormality in chronic lymphocytic leukemia (CLL) and implies a favorable prognosis. We explored the feasibility of detecting del(13q) by real-time quantitative polymerase chain reaction (PCR) for miR-15a and miR-16-1, whose loci are located in the deleted region. We analyzed 23 cases of B-CLL with monoallelic (10 cases) or biallelic del(13q) (5 cases) and used trisomy 12-positive CLL samples (n = 8) as control samples. As expected, miR-15a was expressed at significantly lower levels in monoallelic del(13qx1) samples compared with trisomy 12 control samples (P = .001). Biallelic del(13q) (del(13qx2)) samples showed further reduction of miR-15a levels compared with monoallelic del(13q) (del(13qx1)) (P = .009). In contrast, miR-16-1 expression levels were generally much lower and variable, with the highest levels detected in del(13qx1). Analyzed retrospectively, miR-15a levels differ among the del(13q) groups. However, only del(13qx2) miR-15a levels are reduced enough to determine the allelic status of an individual sample prospectively by real-time quantitative PCR.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22431542     DOI: 10.1309/AJCPP31FSSRQTTAQ

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  7 in total

1.  MicroRNAs and Glucocorticoid-Induced Apoptosis in Lymphoid Malignancies.

Authors:  Ronit Vogt Sionov
Journal:  ISRN Hematol       Date:  2013-01-29

Review 2.  miR deregulation in CLL.

Authors:  Veronica Balatti; Yuri Pekarky; Lara Rizzotto; Carlo M Croce
Journal:  Adv Exp Med Biol       Date:  2013       Impact factor: 2.622

3.  Differential microRNA profiles and their functional implications in different immunogenetic subsets of chronic lymphocytic leukemia.

Authors:  Nikos Papakonstantinou; Stavroula Ntoufa; Elisavet Chartomatsidou; Giorgio Papadopoulos; Artemis Hatzigeorgiou; Achiles Anagnostopoulos; Katerina Chlichlia; Paolo Ghia; Marta Muzio; Chrysoula Belessi; Kostas Stamatopoulos
Journal:  Mol Med       Date:  2013-05-20       Impact factor: 6.354

4.  IL-4 Up-Regulates MiR-21 and the MiRNAs Hosted in the CLCN5 Gene in Chronic Lymphocytic Leukemia.

Authors:  Natalia Ruiz-Lafuente; María-José Alcaraz-García; Silvia Sebastián-Ruiz; Azahara-María García-Serna; Joaquín Gómez-Espuch; José-María Moraleda; Alfredo Minguela; Ana-María García-Alonso; Antonio Parrado
Journal:  PLoS One       Date:  2015-04-24       Impact factor: 3.240

5.  Hsa-miR-15a and Hsa-miR-16-1 expression is not related to proliferation centers abundance and other prognostic factors in chronic lymphocytic leukemia.

Authors:  Maura Rossi; Fabio Fuligni; Maria Ciccone; Claudio Agostinelli; Simona Righi; Marco Luciani; Maria Antonella Laginestra; Gian Matteo Rigolin; Maria Rosaria Sapienza; Anna Gazzola; Claudia Mannu; Antonio Cuneo; Stefano Pileri; Pier Paolo Piccaluga
Journal:  Biomed Res Int       Date:  2013-12-12       Impact factor: 3.411

6.  Low BACH2 Expression Predicts Adverse Outcome in Chronic Lymphocytic Leukaemia.

Authors:  Carmela Ciardullo; Katarzyna Szoltysek; Peixun Zhou; Monika Pietrowska; Lukasz Marczak; Elaine Willmore; Amir Enshaei; Anna Walaszczyk; Jia Yee Ho; Vikki Rand; Scott Marshall; Andrew G Hall; Christine J Harrison; Meera Soundararajan; Jeyanthy Eswaran
Journal:  Cancers (Basel)       Date:  2021-12-21       Impact factor: 6.639

7.  Chromosomal aberrations detected by Fluorescence in situ hybridization in 344 Brazilian chronic lymphocytic leukemia patients.

Authors:  Maria Eduarda Sanseverino de Lourenço da Motta Zorovich; Denise Albuquerque Dourado; Maria de Lourdes Lopes Ferrari Chauffaille
Journal:  Rev Bras Hematol Hemoter       Date:  2017-06-28
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.